AU2526497A - Post-labeling stabilization of radiolabeled proteins and peptides - Google Patents

Post-labeling stabilization of radiolabeled proteins and peptides

Info

Publication number
AU2526497A
AU2526497A AU25264/97A AU2526497A AU2526497A AU 2526497 A AU2526497 A AU 2526497A AU 25264/97 A AU25264/97 A AU 25264/97A AU 2526497 A AU2526497 A AU 2526497A AU 2526497 A AU2526497 A AU 2526497A
Authority
AU
Australia
Prior art keywords
labeling
peptides
stabilization
post
radiolabeled proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
AU25264/97A
Inventor
Michael J. Marek
Paul O Zamora
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rhomed Inc
Original Assignee
Rhomed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhomed Inc filed Critical Rhomed Inc
Publication of AU2526497A publication Critical patent/AU2526497A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1027—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against receptors, cell-surface antigens or cell-surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU25264/97A 1996-02-02 1997-02-03 Post-labeling stabilization of radiolabeled proteins and peptides Withdrawn AU2526497A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1102796P 1996-02-02 1996-02-02
US011027 1996-02-02
PCT/US1997/001695 WO1997028181A2 (en) 1996-02-02 1997-02-03 Post-labeling stabilization of radiolabeled proteins and peptides

Publications (1)

Publication Number Publication Date
AU2526497A true AU2526497A (en) 1997-08-22

Family

ID=21748542

Family Applications (1)

Application Number Title Priority Date Filing Date
AU25264/97A Withdrawn AU2526497A (en) 1996-02-02 1997-02-03 Post-labeling stabilization of radiolabeled proteins and peptides

Country Status (3)

Country Link
AU (1) AU2526497A (en)
CA (1) CA2279349C (en)
WO (1) WO1997028181A2 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7919109B2 (en) 1999-02-08 2011-04-05 Intarcia Therapeutics, Inc. Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
US7258869B1 (en) 1999-02-08 2007-08-21 Alza Corporation Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
AU2002218751A1 (en) * 2000-07-06 2002-01-21 Bristol-Myers Squibb Pharma Company Stable radiopharmaceutical compositions
IL157359A0 (en) * 2001-02-26 2004-02-19 Bristol Myers Squibb Pharma Co A radiopharmaceutical composition containing an ascorbic acid analog
US7238338B1 (en) 2001-06-22 2007-07-03 Triumf System and method for the large scale labeling of compounds with radiohalogens
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
DK2020990T3 (en) 2006-05-30 2010-12-13 Intarcia Therapeutics Inc An internal channel flow modulator for a two-part osmotic feeding system
CA2670821C (en) 2006-08-09 2012-05-15 Intarcia Therapeutics, Inc. Osmotic delivery systems and piston assemblies
MX2009011123A (en) 2007-04-23 2009-11-02 Intarcia Therapeutics Inc Suspension formulations of insulinotropic peptides and uses thereof.
WO2009102467A2 (en) 2008-02-13 2009-08-20 Intarcia Therapeutics, Inc. Devices, formulations, and methods for delivery of multiple beneficial agents
US20100196272A1 (en) * 2009-01-30 2010-08-05 Neoprobe Corporation Compositions for radiolabeling diethylenetriaminepentaacetic acid (dtpa)-dextran
KR101823699B1 (en) 2009-09-28 2018-01-30 인타르시아 세라퓨틱스 인코포레이티드 Rapid establishment and/or termination of substantial steady-state drug delivery
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
AU2016270984B2 (en) 2015-06-03 2021-02-25 Intarcia Therapeutics, Inc. Implant placement and removal systems
CA3016901C (en) * 2016-03-07 2023-06-13 Actinium Pharmaceuticals, Inc. Stabilized radiolabeled anti-cd45 immunoglobulin compositions
AU2017268161B2 (en) 2016-05-16 2020-03-12 Intarcia Therapeutics, Inc. Glucagon-receptor selective polypeptides and methods of use thereof
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
IL307966A (en) 2017-01-03 2023-12-01 Intarcia Therapeutics Inc Methods comprising continuous administration of a glp-1 receptor agonist and co-adminstration of a drug

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4401646A (en) * 1981-05-08 1983-08-30 University Patents Inc. Method and apparatus for purifying materials radiolabeled with technetium-99m
US4988496A (en) * 1988-05-31 1991-01-29 Neorx Corporation Metal radionuclide chelating compounds for improved chelation kinetics
US5011676A (en) * 1990-03-27 1991-04-30 Thomas Jefferson University Method to directly radiolabel antibodies for diagnostic imaging and therapy
DE69231469T2 (en) * 1991-08-29 2001-01-25 Mallinckrodt Medical, Inc. USE OF GENTISIC ACID OR GENTISYL ALCOHOL TO STABILIZE RADIO-LABELED PEPTIDES AND PROTEINS
US5225180A (en) * 1991-09-10 1993-07-06 Diatech, Inc. Technetium-99m labeled somatostatin-derived peptides for imaging

Also Published As

Publication number Publication date
WO1997028181A2 (en) 1997-08-07
CA2279349C (en) 2007-09-25
CA2279349A1 (en) 1997-08-07
WO1997028181A3 (en) 1997-10-09

Similar Documents

Publication Publication Date Title
AU2526497A (en) Post-labeling stabilization of radiolabeled proteins and peptides
EP0785276A4 (en) Modification of peptide and protein
HK1003503A1 (en) Aerosol formulations of peptides and proteins
HUP0000810A3 (en) Proteins with enhanced levels of essential amino acids
EP0880356A4 (en) Antimicrobial peptides and methods of use
EP1071706A4 (en) Rapidly degrading gfp-fusion proteins and methods of use
AU4727296A (en) Polypeptides useful as immunotherapeutic agents and methods of polypeptide preparation
AU2548097A (en) Formulations of ob protein
AU2572797A (en) Adam proteins and uses thereof
AU1159897A (en) Analogs of peptide yy and uses thereof
AU2091799A (en) Uses of alpha-conotoxin peptides
AU6585498A (en) Novel uncoupling protein and methods of use
AU4977796A (en) Modified lysine or arginine containing proteins and peptides
AU4013495A (en) Chemokine-like proteins and methods of use
AU4074997A (en) Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides
AU4236097A (en) Mhc peptides and methods of use
AU7238098A (en) Peptides having cyclic structures and exerting p53 protein activty-restoring effect on p53 protein mutants
AU3451397A (en) Modified protein g and fragments thereof
PL321239A1 (en) Mutations of proteins
EP1029034A4 (en) Signal peptide containing proteins and uses therefor
HUP9801330A3 (en) Novel pka-binding proteins and uses thereof
AU3964499A (en) Agouti-related protein analogs and methods of use
AU6301698A (en) Anti-hiv peptides and proteins
AU4927000A (en) Labelling of peptides and proteins
IL128746A0 (en) Ptx-sensitive g proteins their preparation and use